Therapeutic efficacy of RAS inhibitor trametinib using a juvenile myelomonocytic leukemia patient-derived xenograft model

Alex Q. Leea Department of Pediatrics, UC Davis School of Medicine, Sacramento, California, USAView further author information

Hiroaki Konishia Department of Pediatrics, UC Davis School of Medicine, Sacramento, California, USAView further author information

Masami Ijiria Department of Pediatrics, UC Davis School of Medicine, Sacramento, California, USAView further author information

Yueju Lib Department of Public Health Sciences, UC Davis, Davis, California, USAView further author information

Arun Panigrahia Department of Pediatrics, UC Davis School of Medicine, Sacramento, California, USAView further author information

Jeremy Chienc Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, Sacramento, California, USAView further author information

Noriko Satakea Department of Pediatrics, UC Davis School of Medicine, Sacramento, California, USACorrespondence[email protected]

Your download is now in progress and you may close this window